Pfizer and BioNTech launch trial of Omicron-targeted COVID vaccine
Go back to Pfizer and BioNTech launch trial of Omicron-targeted COVID vaccine| (NASDAQ: BNTX) | Delayed: 90.70 +3.78 (4.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $86.92 | 52 Week High | $ | |||
| Open | $89.24 | 52 Week Low | $ | |||
| Day High | $91.46 | P/E | N/A | |||
| Day Low | $88.25 | EPS | $ | |||
| Volume | 1,352,952 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 30.79 +0.79 (2.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.00 | 52 Week High | $37.39 | |||
| Open | $30.75 | 52 Week Low | $28.25 | |||
| Day High | $30.90 | P/E | 18.66 | |||
| Day Low | $30.04 | EPS | $1.65 | |||
| Volume | 50,598,958 | |||||



